Status:
UNKNOWN
CMR Imaging of Autoimmune Diseases
Lead Sponsor:
King's College London
Collaborating Sponsors:
Guy's and St Thomas' NHS Foundation Trust
Conditions:
Myocarditis
Autoimmune Rheumatologic Disease
Eligibility:
All Genders
18-85 years
Brief Summary
Myocarditis is an important clinical problem which can can occur as a result of viral infections and autoimmune rheumatic diseases. Cardiac MRI is an important non-invasive means of making a diagnosis...
Eligibility Criteria
Inclusion
- All patients referred for CMR for clinically suspected myocarditis either idiopathic or in the context of autoimmune rheumatic disease.
- Patients who are able to give informed consent.
Exclusion
- Patients in atrial fibrillation.
- Patients who are unable to give informed consent.
- Patients whose physical or mental condition indicates that the additional time in the CMR scanner should be minimised.
- Patients who cannot have CMR due to either contraindications to CMR (e.g., non-conditional intracardiac devices) or contraindications to contrast (e.g., history of allergy to gadolinium).
Key Trial Info
Start Date :
November 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT04673409
Start Date
November 24 2020
End Date
June 30 2024
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom, SE1 7EH